Literature DB >> 9508306

Standardized BACTEC method to measure clarithromycin susceptibility of Mycobacterium genavense.

L D Carlson1, C K Wallis, M B Coyle.   

Abstract

A standardized clarithromycin susceptibility test for Mycobacterium genavense is reported. The BACTEC radiometric broth dilution test method recommended for Mycobacterium avium complex was modified to develop a reliable and reproducible procedure. Test development involved optimization of medium pH and inoculum densities for antibiotic vials as well as growth control vials. MIC control organisms included Mycobacterium simiae, Mycobacterium avium, and Mycobacterium xenopi. Growth control vials required two to three inoculum dilutions, which varied for each species. Clarithromycin MICs and MBCs for 12 isolates and 1 colonial variant of M. genavense ranged from < or = 0.06 to 0.25 microg/ml.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9508306      PMCID: PMC104619          DOI: 10.1128/JCM.36.3.748-751.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy.

Authors:  B Ji; N Lounis; C Truffot-Pernot; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria.

Authors:  N Rastogi; K S Goh
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

3.  Bacteriologic investigations of unusual mycobacteria isolated from immunocompromised patients.

Authors:  S H Siddiqi; A Laszlo; W R Butler; J O Kilburn
Journal:  Diagn Microbiol Infect Dis       Date:  1993 May-Jun       Impact factor: 2.803

4.  Cultural studies on two isolates of "Mycobacterium genavense" from patients with acquired immunodeficiency syndrome.

Authors:  E Tortoli; M T Simonetti; D Dionisio; M Meli
Journal:  Diagn Microbiol Infect Dis       Date:  1994-01       Impact factor: 2.803

5.  Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates.

Authors:  S H Siddiqi; L B Heifets; M H Cynamon; N M Hooper; A Laszlo; J P Libonati; P J Lindholm-Levy; N Pearson
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

6.  Invasive infection with Mycobacterium genavense in three children with the acquired immunodeficiency syndrome.

Authors:  D Nadal; R Caduff; R Kraft; M Salfinger; T Bodmer; P Kirschner; E C Böttger; U B Schaad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

7.  Accumulation of clarithromycin in macrophages infected with Mycobacterium avium.

Authors:  N Mor; J Vanderkolk; L Heifets
Journal:  Pharmacotherapy       Date:  1994 Jan-Feb       Impact factor: 4.705

8.  Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year survey.

Authors:  F Portaels; L Realini; L Bauwens; B Hirschel; W M Meyers; W de Meurichy
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

9.  Mycobacterium genavense infections in pet animals.

Authors:  T E Kiehn; H Hoefer; E C Bottger; R Ross; M Wong; F Edwards; N Antinoff; D Armstrong
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

10.  Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy.

Authors:  M T Bessesen; J Shlay; B Stone-Venohr; D L Cohn; R R Reves
Journal:  AIDS       Date:  1993-10       Impact factor: 4.177

View more
  2 in total

1.  One-step synthesis of amine-functionalized hollow mesoporous silica nanoparticles as efficient antibacterial and anticancer materials.

Authors:  Nanjing Hao; Kalana W Jayawardana; Xuan Chen; Mingdi Yan
Journal:  ACS Appl Mater Interfaces       Date:  2015-01-08       Impact factor: 9.229

2.  Carbohydrate-Conjugated Hollow Oblate Mesoporous Silica Nanoparticles as Nanoantibiotics to Target Mycobacteria.

Authors:  Nanjing Hao; Xuan Chen; Seaho Jeon; Mingdi Yan
Journal:  Adv Healthc Mater       Date:  2015-10-09       Impact factor: 9.933

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.